UnitedHealth Group Incorporated $UNH Shares Sold by TD Asset Management Inc

TD Asset Management Inc lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 41.2% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 783,831 shares of the healthcare conglomerate’s stock after selling 549,966 shares during the quarter. TD Asset Management Inc’s holdings in UnitedHealth Group were worth $244,532,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. Brighton Jones LLC lifted its holdings in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after buying an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of UnitedHealth Group by 7.4% in the 1st quarter. GAMMA Investing LLC now owns 15,838 shares of the healthcare conglomerate’s stock valued at $8,295,000 after purchasing an additional 1,089 shares in the last quarter. Sound Income Strategies LLC raised its stake in shares of UnitedHealth Group by 15.9% in the 1st quarter. Sound Income Strategies LLC now owns 2,399 shares of the healthcare conglomerate’s stock valued at $1,257,000 after purchasing an additional 330 shares in the last quarter. Finally, Exchange Traded Concepts LLC raised its stake in shares of UnitedHealth Group by 49.0% in the 1st quarter. Exchange Traded Concepts LLC now owns 2,827 shares of the healthcare conglomerate’s stock valued at $1,481,000 after purchasing an additional 930 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

UNH has been the topic of a number of recent analyst reports. Royal Bank Of Canada cut their target price on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Sanford C. Bernstein boosted their price objective on shares of UnitedHealth Group from $379.00 to $433.00 and gave the company an “outperform” rating in a research report on Wednesday, October 8th. Morgan Stanley boosted their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Truist Financial boosted their price objective on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Finally, Mizuho upped their target price on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $383.09.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $358.80 on Tuesday. The firm’s 50 day moving average is $320.57 and its two-hundred day moving average is $346.99. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The firm has a market capitalization of $324.96 billion, a P/E ratio of 15.55, a PEG ratio of 2.29 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the business earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.